TipRanks on MSN
Philogen’s new phase 2 study: A potential game-changer in basal cell carcinoma treatment
Philogen SpA ($DE:78Q) announced an update on their ongoing clinical study. Philogen S.p.A. is conducting a Phase 2 clinical study titled ‘A Phase ...
Savitri Thakur. New Delhi, Dec 13 (IANS) More than 29.82 lakh phone calls have been handled by 53 Tele MANAS Cells, Minister ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback